What is Abcodia?
Abcodia is a company focused on revolutionizing ovarian cancer risk assessment. It offers the ROCA Test, a blood test designed to evaluate the risk of ovarian cancer in women over 35 who carry BRCA1 or BRCA2 gene mutations. This diagnostic tool provides a crucial option for ongoing surveillance for individuals seeking to delay preventative surgery. The ROCA Test is currently accessible through the NHS in select UK regions and privately in clinics in Cardiff and London, aiming to empower women in managing their genetic predisposition to ovarian cancer.
How much funding has Abcodia raised?
Abcodia has raised a total of $8.2M across 1 funding round:
Unspecified
$8.2M
Unspecified (2015): $8.2M with participation from Scottish Equity Partners, Albion Ventures, UCL Business PLC, and Cambridge Innovation Capital
Key Investors in Abcodia
Scottish Equity Partners
Scottish Equity Partners (SEP) is a prominent growth equity investor specializing in UK and European enterprise software and technology scaleups, providing capital and resources for growth.
Albion Ventures
AlbionVC, the technology investment arm of Albion Capital Group, focuses on high-growth B2B software and tech-enabled services companies, primarily in the UK, from seed to Series B.
UCL Business PLC
UCL Business PLC (UCLB) is the commercialisation arm of University College London, dedicated to bringing world-leading technologies and innovations from UCL academics and hospitals to market.
What's next for Abcodia?
With a substantial enterprise-level funding context, Abcodia is poised for significant expansion and market penetration. The recent strategic investment will likely fuel further development of the ROCA Test, potentially broadening its availability and clinical integration. Future efforts may focus on enhancing diagnostic capabilities, expanding geographical reach, and forging new partnerships within the healthcare and biotechnology sectors to solidify its position as a leader in genetic risk assessment for ovarian cancer.
See full Abcodia company page
